Search Results
Search for other papers by Louis de Mestier in
Google Scholar
PubMed
Search for other papers by Angela Lamarca in
Google Scholar
PubMed
Search for other papers by Jorge Hernando in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Search for other papers by Wouter Zandee in
Google Scholar
PubMed
Search for other papers by Teresa Alonso-Gordoa in
Google Scholar
PubMed
Search for other papers by Marine Perrier in
Google Scholar
PubMed
Search for other papers by Annemiek ME Walenkamp in
Google Scholar
PubMed
Search for other papers by Bipasha Chakrabarty in
Google Scholar
PubMed
Search for other papers by Stefania Landolfi in
Google Scholar
PubMed
Search for other papers by Marie-Louise F Van Velthuysen in
Google Scholar
PubMed
Search for other papers by Gursah Kats-Ugurlu in
Google Scholar
PubMed
Search for other papers by Alejandra Caminoa in
Google Scholar
PubMed
Search for other papers by Maxime Ronot in
Google Scholar
PubMed
Search for other papers by Prakash Manoharan in
Google Scholar
PubMed
Search for other papers by Alejandro Garcia-Alvarez in
Google Scholar
PubMed
Search for other papers by Tessa Brabander in
Google Scholar
PubMed
Search for other papers by María Isabel García Gómez-Muriel in
Google Scholar
PubMed
Search for other papers by Guillaume Cadiot in
Google Scholar
PubMed
Search for other papers by Anne Couvelard in
Google Scholar
PubMed
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Marianne E Pavel in
Google Scholar
PubMed
Search for other papers by Jérôme Cros in
Google Scholar
PubMed
Introduction The classification of neuroendocrine neoplasms (NENs) relies on differentiation (well-differentiated neuroendocrine tumors (NETs) or poorly-differentiated neuroendocrine carcinomas (NECs)) and the proliferation index, which is
Search for other papers by Lena Weindl in
Google Scholar
PubMed
Search for other papers by Imke Atreya in
Google Scholar
PubMed
Institute of Biochemistry, Emil-Fischer-Zentrum, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
Search for other papers by Peter Dietrich in
Google Scholar
PubMed
Search for other papers by Sabine Neubeck in
Google Scholar
PubMed
Deutsches Zentrum Immuntherapie DZI, Erlangen, Germany
Comprehensive Cancer Center CCC-EMN, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
Search for other papers by Markus F Neurath in
Google Scholar
PubMed
Deutsches Zentrum Immuntherapie DZI, Erlangen, Germany
Comprehensive Cancer Center CCC-EMN, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany
Search for other papers by Marianne Pavel in
Google Scholar
PubMed
of the latest evidence, further separation of high-grade NENs into well differentiated neuroendocrine tumors (NETs G3) and poorly differentiated neuroendocrine carcinomas (NECs G3) is emerging due to prognostic relevance ( Sorbye et al. 2013
Search for other papers by Martin B Niederle in
Google Scholar
PubMed
Search for other papers by Monika Hackl in
Google Scholar
PubMed
Search for other papers by Klaus Kaserer in
Google Scholar
PubMed
Search for other papers by Bruno Niederle in
Google Scholar
PubMed
, as ‘well differentiated’ tumours with either ‘benign’ or ‘uncertain’ behaviour or as ‘well differentiated’ or ‘poorly differentiated’ neuroendocrine carcinomas. Neuroendocrine liver tumours were included in the analysis if no other neuroendocrine
Search for other papers by S Felder in
Google Scholar
PubMed
Search for other papers by H Jann in
Google Scholar
PubMed
Search for other papers by R Arsenic in
Google Scholar
PubMed
Search for other papers by T Denecke in
Google Scholar
PubMed
Klinik für Nuklearmedizin, Universitätklinikum Ulm, Ulm, Germany
Search for other papers by V Prasad in
Google Scholar
PubMed
Search for other papers by B Knappe-Drzikova in
Google Scholar
PubMed
Innere Medizin und Gastroenterologie, Asklepios Klinik St. Georg, Asklepios Medical School, Hamburg, Germany
Search for other papers by S Maasberg in
Google Scholar
PubMed
Search for other papers by B Wiedenmann in
Google Scholar
PubMed
Medizinische Klinik 1, Gastroenterologie, Pneumologie und Endokrinologie, Universitätsklinikum der Friedrich-Alexander Universität Erlangen, Erlangen, Germany
Search for other papers by M Pavel in
Google Scholar
PubMed
Klinik für Allgemein-, Viszeral- und Transplantationschirurgie, Uinversitätsklinikum Münster, Münster, Germany
Search for other papers by A Pascher in
Google Scholar
PubMed
Innere Medizin und Gastroenterologie, Asklepios Klinik St. Georg, Asklepios Medical School, Hamburg, Germany
Search for other papers by U F Pape in
Google Scholar
PubMed
://doi.org/10.1055/s-2003-37256 ) 12584637 Ishida M Sekine S Fukagawa T Ohashi M Morita S Taniguchi H Katai H Tsuda H Kushima R 2013 Neuroendocrine carcinoma of the stomach: morphologic and immunohistochemical characteristics and
Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed
Clinic for Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland
Search for other papers by Ariadni Spyroglou in
Google Scholar
PubMed
Search for other papers by Stylianos Kykalos in
Google Scholar
PubMed
Endocrine Unit, First Department of Propaedeutic Medicine, Laiko University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Search for other papers by Kosmas Daskalakis in
Google Scholar
PubMed
Search for other papers by Georgios Kyriakopoulos in
Google Scholar
PubMed
Search for other papers by Georgios C Sotiropoulos in
Google Scholar
PubMed
Search for other papers by Gregory A Kaltsas in
Google Scholar
PubMed
NET Unit, Royal Free Hospital, London, UK
Barts and the London School of Medicine, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
reflect their biological behaviour, ranging from the well-differentiated neuroendocrine tumours (NETs) to the poorly differentiated neuroendocrine carcinomas (NECs) ( Nagtegaal et al. 2020 ). The Ki-67 protein is a cellular proliferation marker, useful
Search for other papers by Maria Chiara Zatelli in
Google Scholar
PubMed
Search for other papers by Giuseppe Fanciulli in
Google Scholar
PubMed
Search for other papers by Pasqualino Malandrino in
Google Scholar
PubMed
Search for other papers by Valeria Ramundo in
Google Scholar
PubMed
Search for other papers by Antongiulio Faggiano in
Google Scholar
PubMed
Search for other papers by Annamaria Colao in
Google Scholar
PubMed
Search for other papers by on behalf of NIKE Group in
Google Scholar
PubMed
considered. The search strategy included the following terms: ‘neuroendocrine tumour’, ‘neuroendocrine carcinoma’, ‘predictive’, ‘response’, ‘everolimus’, ‘temsirolimus’ or ‘rapamycin’. Additional studies were identified by reviewing the references of all
NHS Nightingale Hospital London, London, UK
Search for other papers by Ashley K Clift in
Google Scholar
PubMed
Search for other papers by Andrea Frilling in
Google Scholar
PubMed
proliferative capacity and degree of differentiation into neuroendocrine tumours (NET) or neuroendocrine carcinoma (NEC) ( Rindi et al. 2007 ). The former is relatively indolent as compared to adenocarcinomas arising from the same organs but display stark
Search for other papers by Corinne Gérard in
Google Scholar
PubMed
Search for other papers by Marie Lagarde in
Google Scholar
PubMed
Search for other papers by Flora Poizat in
Google Scholar
PubMed
Search for other papers by Sandrine Oziel-Taieb in
Google Scholar
PubMed
Search for other papers by Vincent Garcia in
Google Scholar
PubMed
Search for other papers by Catherine Roche in
Google Scholar
PubMed
Search for other papers by Patricia Niccoli in
Google Scholar
PubMed
Molecular Biology Laboratory, Hospital La Conception, AP-HM, Marseille, France
Search for other papers by Anne Barlier in
Google Scholar
PubMed
Search for other papers by David Romano in
Google Scholar
PubMed
progression free survival ( Pavel et al. 2011 , Yao et al. 2016 ). Cytotoxic agents are recommended in the ENETS consensus Guidelines for patients with poorly differentiated neuroendocrine carcinomas (NECs), as well as for those with well
Search for other papers by Tobias Hofving in
Google Scholar
PubMed
Search for other papers by Viktor Sandblom in
Google Scholar
PubMed
Search for other papers by Yvonne Arvidsson in
Google Scholar
PubMed
Search for other papers by Emman Shubbar in
Google Scholar
PubMed
Search for other papers by Gülay Altiparmak in
Google Scholar
PubMed
Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by John Swanpalmer in
Google Scholar
PubMed
Search for other papers by Bilal Almobarak in
Google Scholar
PubMed
Search for other papers by Anna-Karin Elf in
Google Scholar
PubMed
Search for other papers by Viktor Johanson in
Google Scholar
PubMed
Search for other papers by Erik Elias in
Google Scholar
PubMed
Search for other papers by Erik Kristiansson in
Google Scholar
PubMed
Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Eva Forssell-Aronsson in
Google Scholar
PubMed
Search for other papers by Ola Nilsson in
Google Scholar
PubMed
disease. In fact, P-STS was established from the primary tumour of a grade 3 poorly differentiated neuroendocrine carcinoma ( Pfragner et al. 2009 ). GOT1 and ex vivo cultures were unlike P-STS established from metastatic grade 1 or 2 well
Search for other papers by Darren Cowzer in
Google Scholar
PubMed
Search for other papers by Ronak H Shah in
Google Scholar
PubMed
Search for other papers by Joanne F Chou in
Google Scholar
PubMed
Search for other papers by Ritika Kundra in
Google Scholar
PubMed
Search for other papers by Sippy Punn in
Google Scholar
PubMed
Search for other papers by Laura Fiedler in
Google Scholar
PubMed
Search for other papers by April DeMore in
Google Scholar
PubMed
Search for other papers by Marinela Capanu in
Google Scholar
PubMed
Department of Pathology and laboratory medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Search for other papers by Michael F Berger in
Google Scholar
PubMed
Weill Medical College of Cornell University, New York, New York, USA
Search for other papers by Diane Reidy-Lagunes in
Google Scholar
PubMed
Weill Medical College of Cornell University, New York, New York, USA
Search for other papers by Nitya Raj in
Google Scholar
PubMed
neuroendocrine tumor (WD-NET) and poorly differentiated neuroendocrine carcinoma (PD-NEC) of the pancreas . American Journal of Surgical Pathology 40 1192 – 1202 . ( https://doi.org/10.1097/PAS.0000000000000662 ) Tie J Cohen JD Lahouel K Lo SN Wang Y